EU Agencies Call Attention To Link Between Black Cohosh, Liver Risks
This article was originally published in The Tan Sheet
Executive Summary
The UK's Medicines & Healthcare products Regulatory Agency (MHRA) will add warnings to black cohosh products about the risk of liver disorders associated with use of the herbal, the agency states in a release July 18
You may also be interested in...
Black Cohosh Case Report Used By Foreign Health Bodies Cast Into Doubt
Expert testimony during a black cohosh lawsuit exposed the omission of relevant data in a published case report alleging a causal relationship between the botanical and liver damage. A U.S. District Court dismissed the suit Sept. 8 due to the plaintiffs' inability to establish causation
Black Cohosh Case Report Used By Foreign Health Bodies Cast Into Doubt
Expert testimony during a black cohosh lawsuit exposed the omission of relevant data in a published case report alleging a causal relationship between the botanical and liver damage. A U.S. District Court dismissed the suit Sept. 8 due to the plaintiffs' inability to establish causation
Black Cohosh Case Report Used By Foreign Health Bodies Cast Into Doubt
Expert testimony during a black cohosh lawsuit exposed the omission of relevant data in a published case report alleging a causal relationship between the botanical and liver damage. A U.S. District Court dismissed the suit Sept. 8 due to the plaintiffs' inability to establish causation